We are live on
!
Find out more
PP
PDT Partners Portfolio holdings
AUM
$1.69B
1-Year Est. Return
74.01%
This Fund
S&P 500
This Quarter
Est. Return
+11.5%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.62B
AUM Growth
-$62.4M
(-3.7%)
Cap. Flow
-$203M
Cap. Flow
% of AUM
-12.53%
Top 10 Holdings %
Top 10 Hldgs %
11.78%
Holding
792
New
346
Increased
157
Reduced
185
Closed
89
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$9.44M |
| 2 |
Lowe's Companies
LOW
|
+$9.42M |
| 3 |
Electronic Arts
EA
|
+$9.24M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$9M |
| 5 |
Costco
COST
|
+$8.92M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$46.2M |
| 2 |
AbbVie
ABBV
|
+$29.9M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$27.4M |
| 4 |
eBay
EBAY
|
+$20.5M |
| 5 |
Atlassian
TEAM
|
+$19.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.95% |
| 2 | Technology | 18.44% |
| 3 | Consumer Discretionary | 15.45% |
| 4 | Industrials | 9.36% |
| 5 | Financials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADMS
501
DELISTED
Adamas Pharmaceuticals
ADMS
| $353K | 0.02% |
93,104
+39,904
| +75% | +$191K |
|
502
Snap
SNAP
$7.6B
| $348K | 0.02% |
+21,298
| New | +$313K |
|
503
Valmont Industries
VMI
$9.61B
| $346K | 0.02% |
+2,312
| New | +$327K |
|
504
Webster Financial
WBS
$12.5B
| $345K | 0.02% |
+6,460
| New | +$311K |
|
|
SGEN
505
DELISTED
Seagen Inc. Common Stock
SGEN
| $344K | 0.02% |
+3,010
| New | +$319K |
|
506
Mercado Libre
MELI
$92.3B
| $343K | 0.02% |
+600
| New | +$332K |
|
507
Prothena Corp
PRTA
$455M
| $340K | 0.02% |
21,500
-15,888
| -42% | -$170K |
|
508
Columbia Financial
CLBK
$1.13B
| $339K | 0.02% |
20,028
-4,277
| -18% | -$70.6K |
|
509
Alarm.com
ALRM
$2.65B
| $338K | 0.02% |
+7,870
| New | +$355K |
|
510
SolarEdge
SEDG
$2.62B
| $337K | 0.02% |
+3,549
| New | +$303K |
|
511
Broadridge
BR
$17.7B
| $336K | 0.02% |
+2,721
| New | +$333K |
|
512
Fortis
FTS
$29.7B
| $336K | 0.02% |
+8,100
| New | +$331K |
|
513
Advanced Micro Devices
AMD
$807B
| $335K | 0.02% |
+7,308
| New | +$269K |
|
514
Copa Holdings
CPA
$5.65B
| $335K | 0.02% |
+3,100
| New | +$323K |
|
515
Hudbay
HBM
$9.96B
| $335K | 0.02% |
+80,610
| New | +$292K |
|
516
AGCO
AGCO
$8.71B
| $334K | 0.02% |
+4,318
| New | +$331K |
|
517
RenaissanceRe
RNR
$13.7B
| $334K | 0.02% |
+1,705
| New | +$323K |
|
518
nVent Electric
NVT
$24.1B
| $333K | 0.02% |
+13,000
| New | +$302K |
|
|
SPWR
519
DELISTED
SunPower Corporation Common Stock
SPWR
| $333K | 0.02% |
+65,218
| New | +$363K |
|
520
Sensient Technologies
SXT
$5.32B
| $329K | 0.02% |
+4,971
| New | +$318K |
|
|
ATNX
521
DELISTED
Athenex, Inc. Common Stock
ATNX
| $327K | 0.02% |
+1,072
| New | +$283K |
|
|
LJPC
522
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $324K | 0.02% |
82,364
+22,822
| +38% | +$135K |
|
|
EPAY
523
DELISTED
Bottomline Technologies Inc
EPAY
| $318K | 0.02% |
+5,928
| New | +$270K |
|
524
TG Therapeutics
TGTX
$8.53B
| $317K | 0.02% |
+28,596
| New | +$217K |
|
|
FPRX
525
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $317K | 0.02% |
69,100
-19,200
| -22% | -$76K |
|
Similar funds
ISS
GAM
BCM
FACM
TCBWMS
WAS
SGI
AAM
PDT Partners's Q4 2019 Portfolio in Review
As of Q4 2019, PDT Partners held 792 positions worth $1.62B, down 3.7% from $1.68B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
PDT Partners withdrew a net $203M in Q4 2019, closing 89 positions and reducing 185 holdings. Its most notable exit was Linde, an estimated $46.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, PDT Partners opened a new position in Micron Technology worth $10.6M.
- PDT Partners's largest Q4 2019 buy was Micron Technology: 197,601 shares worth $10.6M.
- PDT Partners added most to Bausch Health in Q4 2019, an estimated $5.3M increase.
- PDT Partners's biggest Q4 2019 reduction was AbbVie, cutting an estimated $29.9M.
- PDT Partners fully exited Linde in Q4 2019, selling an estimated $46.2M.
- PDT Partners's ten largest holdings make up 12% of its $1.62B portfolio in Q4 2019.
- PDT Partners opened 346 new positions and closed 89 in Q4 2019.
- PDT Partners's portfolio value fell 3.7% quarter-over-quarter to $1.62B.
Based on PDT Partners's 13F filing for Q4 2019, filed 14 Feb 2020.